Fingerprint
Dive into the research topics of 'Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5
Robert F. Kushner*, Salvatore Calanna, Melanie Davies, Dror Dicker, W. Timothy Garvey, Bryan Goldman, Ildiko Lingvay, Mette Thomsen, Thomas A. Wadden, Sean Wharton, John P.H. Wilding, Domenica Rubino
*Corresponding author for this work
- Northwestern University
- Novo Nordisk Foundation
- University of Leicester
- National Institute for Health and Care Research
- Rabin Medical Center Israel
- University of Alabama at Birmingham
- Department of Veterans Affairs
- University of Texas Southwestern Medical Center
- University of Pennsylvania
- York University Toronto
- University of Liverpool
- Washington Center for Weight Management and Research
Research output: Contribution to journal › Article › peer-review
170
Scopus
citations